Regado Biosciences, Inc. (“Regado” or the “Company”) is a development stage biotechnology company whose mission is to transform lives through the discovery and development of novel therapeutics. The Company applies its expertise to the development of therapies using actively controlled aptamer technology which is designed to give physicians the ability to control the therapeutic effect in real time.The Company is publicly traded (NASDAQ: RGDO) and headquartered in Basking Ridge, New Jersey with R&D facilities in North Carolina.